"Obesity" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A status with BODY WEIGHT that is grossly above the acceptable or desirable weight, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Descriptor ID |
D009765
|
| MeSH Number(s) |
C18.654.726.500 C23.888.144.699.500 E01.370.600.115.100.160.120.699.500 G07.100.100.160.120.699.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Obesity".
Below are MeSH descriptors whose meaning is more specific than "Obesity".
This graph shows the total number of publications written about "Obesity" by people in this website by year, and whether "Obesity" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 7 | 2 | 9 |
| 1997 | 6 | 6 | 12 |
| 1998 | 10 | 7 | 17 |
| 1999 | 15 | 2 | 17 |
| 2000 | 16 | 4 | 20 |
| 2001 | 14 | 1 | 15 |
| 2002 | 19 | 6 | 25 |
| 2003 | 33 | 9 | 42 |
| 2004 | 28 | 20 | 48 |
| 2005 | 34 | 10 | 44 |
| 2006 | 36 | 13 | 49 |
| 2007 | 31 | 13 | 44 |
| 2008 | 41 | 13 | 54 |
| 2009 | 40 | 12 | 52 |
| 2010 | 45 | 24 | 69 |
| 2011 | 59 | 24 | 83 |
| 2012 | 66 | 23 | 89 |
| 2013 | 87 | 42 | 129 |
| 2014 | 59 | 27 | 86 |
| 2015 | 56 | 26 | 82 |
| 2016 | 50 | 26 | 76 |
| 2017 | 60 | 21 | 81 |
| 2018 | 46 | 20 | 66 |
| 2019 | 42 | 19 | 61 |
| 2020 | 43 | 35 | 78 |
| 2021 | 34 | 48 | 82 |
| 2022 | 11 | 61 | 72 |
| 2023 | 16 | 49 | 65 |
| 2024 | 28 | 31 | 59 |
| 2025 | 32 | 10 | 42 |
| 2026 | 3 | 2 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Obesity" by people in Profiles.
-
Community Participatory Co-Design and Development of a Digital Diabetes Prevention Education Program for Hispanic Families With Obesity: Mixed Methods Study. JMIR Form Res. 2026 Feb 11; 10:e67800.
-
Testosterone plus lifestyle therapy improves skeletal muscle glycolysis in older men with obesity and hypogonadism. Front Endocrinol (Lausanne). 2025; 16:1719749.
-
Myokine SIRPa exacerbates kidney disease in diabetes. JCI Insight. 2026 Feb 09; 11(3).
-
Pre-diagnostic body mass index trajectories and associations with lung cancer risk. Am J Epidemiol. 2026 Feb 05; 195(2):358-366.
-
Circulating metabolites, genetics and lifestyle factors in relation to future risk of type 2 diabetes. Nat Med. 2026 Feb; 32(2):660-670.
-
Real-World Evidence on Weight Loss and Safety With Semaglutide in Obesity Telehealth: A Large Retrospective Cohort Study. Obesity (Silver Spring). 2026 Mar; 34(3):729-737.
-
Epigenome-wide association study meta-analysis of BMI in African Americans. HGG Adv. 2026 Jan 15; 7(1):100552.
-
The Benefits of Exercise Training in Combination With Weight Loss Therapies. Diabetes. 2025 Dec 01; 74(12):2199-2206.
-
Pharmacological treatment for patients with obesity and heart failure: Focus on glucagon-like peptide-1 receptor agonists. European Journal of Heart Failure expert consensus document. Eur J Heart Fail. 2025 Nov; 27(11):2465-2479.
-
Deletion of fibro-adipogenic progenitors-specific follistatin impairs muscle function and accelerates skeletal muscle atrophy in obese mice. Mol Med. 2025 Nov 21; 31(1):340.